Back

Association of PCI with outcomes in stable coronary artery disease

1 September 2024 (13:00 - 13:50)
Organised by: Logo
Congress Presentation Part of: Risk stratification in percutaneous coronary intervention (2) Revascularisation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Jordan Price

Stony Brook University Hospital, Stony Brook (United States of America)

8 More presentations in this session

Presentation thumbnail
Twelve-month outcome of robotic assisted PCI
Doctor J. Rilinger (Freiburg, DE)
Abstract Slides Video
Presentation thumbnail
Revascularization strategies in elderly patients with acute coronary syndromes and multivessel disease: comparative analysis of culprit-only vs complete revascularization
Mr A. Rocha De Almeida (Evora, PT)
Abstract Slides Video
Presentation thumbnail
Mechanisms leading to peri-procedural myocardial infarction in patients with focal versus diffuse coronary artery disease
Doctor D. Munhoz (Aalst, BE)
Abstract Slides Video
Presentation thumbnail
Prevalance and impact of concomitant atrial fibrillation in patients undergoing percutaneous coronary intervention for acute myocardial infarction
Doctor S. Mahajan (Birmingham, GB)
Abstract Slides Video
Presentation thumbnail
The impact of high-intensity statin on 3-year clinical outcomes in elderly acute myocardial infarction patients underwent percutaneous coronary intervention with drug-eluting stents
Professor A. Her (Chuncheon, KR)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in percutaneous coronary intervention (2)

The Event

Event poster

ESC Congress 2024

1 September 2024 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Long-term outcomes of single-session versus staged strategies for elective multivessel percutaneous coronary intervention
thumbnail
Congress Session
Revascularisation in chronic coronary syndrome
thumbnail
Congress Presentation
Percutaneous coronary intervention and medical therapy versus medical therapy alone in chronic coronary syndrome: A hierarchical win-ratio analysis from SCAAR

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources